Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
Bronstein, Gewirtz & Grossman, LLC Is Investigating Johnson & Johnson (JNJ) And Encourages Stockholders to Connect
10:00am, Wednesday, 15'th Jan 2025
NEW YORK, NY / ACCESSWIRE / January 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Johnson & Johnson ("J&J" or "the Company") (NYSE:JNJ). In
JNJ ALERT - Levi & Korsinsky Has Commenced an Investigation on Behalf of Johnson & Johnson Shareholders Who Lost Money
08:15am, Wednesday, 15'th Jan 2025
NEW YORK, NY / ACCESSWIRE / January 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Johnson & Johnson ("Johnson & Johnson") (NYSE:JNJ) concerning possible viol
Application accepted for U.S. FDA Real-Time Oncology Review (RTOR) based on Phase 2b SunRISe-1 study showing highest single-agent complete response rate of 83.5 percent1 RARITAN, N.J. , Jan. 15, 2025
Got $200? 2 Dividend Stocks to Buy and Hold Forever
05:10am, Wednesday, 15'th Jan 2025
Medicine is the cornerstone of healthcare. That remains true today, with a global pharmaceutical industry valued at $1.4 trillion and expected to grow at 6.1% annually through 2030.
JNJ, GSK, LLY Announce M&A Deals at JP Morgan Conference
04:00pm, Tuesday, 14'th Jan 2025
J&J announces a big deal to acquire neuroscience company ITCI for $14.6 billion, while Lilly and GSK announce smaller deals.
JNJ ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Johnson & Johnson Shareholders Who Lost Money
10:30am, Tuesday, 14'th Jan 2025
NEW YORK, NY / ACCESSWIRE / January 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Johnson & Johnson ("Johnson & Johnson") (NYSE:JNJ) concerning possible viol
Is Trending Stock Johnson & Johnson (JNJ) a Buy Now?
10:01am, Tuesday, 14'th Jan 2025
Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
NEW YORK, NY / ACCESSWIRE / January 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Johnson & Johnson ("J&J" or "the Company") (NYSE:JNJ). In
7 Blue Chip Dividend Stocks I Used To Build My First $100K Portfolio
06:00am, Tuesday, 14'th Jan 2025
Building good financial habits and avoiding debt traps is the hardest part of accumulating your first $100K. Invest in companies with growing earnings, consistent dividends, low debt, and an establish
Trellus Health shares jump 180% on Johnson & Johnson collaboration
03:58am, Tuesday, 14'th Jan 2025
Shares in Trellus Health PLC (AIM:TRLS) soared 180% after the company announced a collaboration with Johnson & Johnson (NYSE:JNJ) Health Care Systems Inc. The partnership will pilot Trellus Health's
Healthcare sector poised for rebound in 2025
08:00pm, Monday, 13'th Jan 2025
The JPMorgan Healthcare Conference is a place where deals happen. As the conference kicked off, deals were announced from Eli Lilly (LLY), Johnson & Johnson (JNJ), and GSK (GSK).
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Intra-Cellul
Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025
06:10pm, Monday, 13'th Jan 2025
This article will provide an in-depth analysis of drugs being developed to combat cancer. Big Pharma is keenly interested in the global cancer therapeutics market, which is expected to exceed $400 bil
Johnson & Johnson (JNJ) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)
04:27pm, Monday, 13'th Jan 2025
Johnson & Johnson (NYSE:JNJ ) 43rd Annual J.P. Morgan Healthcare Conference January 13, 2024 12:00 PM ET Company Participants Joaquin Duato - Chairman & CEO Conference Call Participants Chris Schott -
BofA moves to No Rating on Intra-Cellular after Johnson & Johnson deal
02:23pm, Monday, 13'th Jan 2025
Intra-Cellular +32.49 (+34.25%) Johnson & Johnson +2.22 (+1.56%)
